MOLECULAR CHARACTERIZATION, VIRULENCE, AND ANTIMICROBIAL SUSCEPTIBILITY OF MYCOPLASMA BOVIS ASSOCIATED WITH CHRONIC MASTITIS IN DAIRY COWS

Mycoplasma bovis in dairy cows

Authors

  • Magdy Gioushy Department of Animal Medicine, Faculty of Veterinary Medicine, Aswan University, Aswan 37916, Egypt
  • Eid Elsaid Abdelaziz Soliman Mycoplasma department Animal Health Research Institute, Dokki, Giza, 12618, Egypt
  • Rasha M. Elkenany Department of Bacteriology, Mycology and Immunology, Faculty of Veterinary Medicine, Mansoura University, Mansoura, 35516, Egypt
  • El-Sayed El-Alfy Department of parasitology, Faculty of Veterinary Medicine, Mansoura University, Mansoura, 35516, Egypt
  • Ahmed Abd Elaal Department of Animal Medicine, Faculty of Veterinary Medicine, Zagazig University, Zagazig 44511, Egypt
  • Khaled Abd-El Hamid Abd-El Razik Department of Animal Reproduction, National Research Center, Giza, 12622, Egypt
  • Sabry El-Khodery * Department of Internal Medicine and Infectious Diseases, Faculty of Veterinary Medicine, Mansoura University, Mansoura, 35516, Egypt, khodery@mans.edu.eg https://orcid.org/0000-0002-0545-5827

DOI:

https://doi.org/10.26873/SVR-1882-2024

Keywords:

antimicrobial susceptibility, chronic mastitis, Mycoplasma bovis, sequence analysis, virulence genes

Abstract

Mycoplasma bovis (M. bovis) is the most common Mycoplasma species, which has a growing impact on the dairy industry. The purpose of this study was to investigate the molecular characterization, virulence, and antibiotic susceptibility of M. bovis isolates from dairy cows with chronic mastitis in Egypt. Eighty-four composite milk samples from mastitic cows were aseptically collected from dairy farms in Egypt. Based on microbiological examination and the polymerase chain reaction (PCR) technique targeting the 16S rRNA, 14 (16.7%) of all milk samples were positive for Mycoplasma spp. PCR targeting M. bovis-specific gene identified six (7.14%) of the 14 mycoplasma isolates as M. bovis. PCR assays for different virulence genes showed that all M. bovis isolates exhibited the presence of vspA gene, while other virulence genes (uvrC, gap, and p40 pseudogenes) were determined in only two M. bovis isolates (2/6). The 16S rRNA gene phylogenetic analysis demonstrated 100% homology with reference strains of M. bovis isolated from different species and locations. When compared to other isolates in the GenBank, the amino acid sequence alignment of our isolate vspA-like protein indicated a distinct mutation. The in vitro antimicrobial susceptibility testing of the six M. bovis isolates in this study to seven antimicrobial drugs revealed that tilmycosin and tylosin had the lowest minimum inhibitory concentrations (MIC) values (≤1 μg/mL), while danofloxacin, streptomycin and florfenicol had the highest MIC values (<4 μg/mL). Nonetheless, this study showed the virulence of M. bovis in dairy cows in Egypt, and macrolides were found to be the most potent compounds in vitro against all tested isolates, but further studies in nationwide surveys are needed.

Molekularna karakterizacija, virulenca in protimikrobna občutljivost z mikoplazmo M. bovis povezanega kroničnega mastitisa pri kravah molznicah

Izvleček: Mycoplasma bovis (M. bovis) je najpogostejša vrsta mikoplazme, ki ima vse večji vpliv na mlečno industrijo. Namen te študije je bil molekularno karakterizirati in raziskati virulenco in občutljivost izolatov M. bovis za antibiotike, in sicer iz krav molznic s kroničnim mastitisom v Egiptu. Štiriinosemdeset mešanih vzorcev mleka krav z mastitisom je bilo aseptično zbranih na mlečnih farmah v Egiptu. Na podlagi mikrobiološkega pregleda in analize izražanja 16S rRNA z verižno reakcijo s polimerazo (PCR) je bilo 14 (16,7 %) od vseh vzorcev mleka pozitivnih na Mycoplasma spp. Z metodo PCR smo šest (7,14 %) od 14 izolatov mikoplazme identificirali kot M. bovis. Analize PCR za različne gene virulence so pokazale, da je bil pri vseh izolatih M. bovis prisoten gen vspA, medtem ko so bili drugi geni virulence (uvrC, gap in psevdogeni p40) izraženi le pri dveh izolatih M. bovis (2/6). Filogenetska analiza gena 16S rRNA je pokazala 100-odstotno homolognost z referenčnimi sevi M. bovis, izoliranimi iz različnih vrst in lokacij. V primerjavi z drugimi izolati podatkovne zbirke GenBank je poravnava aminokislinskega zaporedja proteina, podobnega VspA, pokazala na značilno mutacijo. In vitro testiranje protimikrobne občutljivosti šestih izolatov M. bovis za sedem protimikrobnih zdravil je pokazalo, da sta imela tilmikozin in tilozin najnižje vrednosti minimalnih inhibitornih koncentracij (MIC) (≤1 μg/ml), medtem ko so imeli danofloksacin, streptomicin in florfenikol najvišje vrednosti MIC (<4 μg/ml). Kljub temu da je ta študija pokazala virulenco M. bovis pri kravah molznicah v Egiptu, makrolidi pa so se izkazali za najmočnejše spojine proti vsem in vitro testiranim izolatom, so potrebne nadaljnje študije v nacionalnih raziskavah.

Ključne besede: antimikrobna občutljivost; kronični mastitis; Mycoplasma bovis; analiza zaporedja; geni virulence

References

1. Abd El Tawab AA, El-hofy FI, Hassan NI et al. Prevalence of Mycoplasma bovis in bovine clinical mastitis milk in Egypt. Benha Vet Med J 2019; 36(2): 57-65. doi: 10.21608/BVMJ.2019.13850.1025

2. Ulloa F, Soto JP, Kruze, J, et al. Mycoplasma isolation in milk samples from dairy herds in Chile. Austral J Vet Sci 2021; 53(2): 109–13. doi: 10.4067/S0719-81322021000200109

3. Liu Y, Xu S, Li M, et al. Molecular characteristics and antibiotic susceptibility profiles of Mycoplasma bovis associated with mastitis on dairy farms in China. Prev Vet Med 2020; 182: 105106. doi: 10.1016/j.prevetmed.2020.105106

4. Nicholas RA, Fox LK, Lysnyansky I. Mycoplasma mastitis in cattle: to cull or not to cull. Vet J 2016; 216: 142–7. doi: : 10.1016/j.tvjl.2016.08.001

5. Fox LK. Mycoplasma mastitis: causes, transmission, and control. Vet Clin North Am Food Anim Pract 2012; 28(2): 225–37. doi: 10.1016/j.cvfa.2012.03.007

6. Maunsell F, Woolums A, Francoz D, et al. Mycoplasma bovis infections in cattle. J Vet Intern Med 2011; 25(4): 772–83. doi: 10.1111/j.1939-1676.2011.0750.x

7. Salina A, Timenetsky J, Barbosa MS, et al. Microbiological and molecular detection of Mycoplasma bovis in milk samples from bovine clinical mastitis. Pesq Vet Bras 2020; 40(2): 82–7. doi: 10.1590/1678-5150-PVB-6259

8. Alberti A, Addis MF, Chessa B, et al. Molecular and antigenic characterization of a Mycoplasma bovis strain causing an outbreak of infectious keratoconjunctivitis. J Vet Diagn Invest 2006; 18(1): 41–51. doi: 10.1177/104063870601800106

9. Abdelazeem WM, Zolnikov TR, Mohammed ZR, et al. Virulence, antimicrobial resistance and phylogenetic analysis of zoonotic walking pneumonia Mycoplasma arginini in the one-humped camel (Camelus dromedarius). Acta trop 2020; 207: 105500. doi: 10.1016/j.actatropica.2020.105500

10. Gelgie AE, Korsa MG, Dego OK. Mycoplasma bovis Mastitis. Curr Res Microb Sci 2022; 3: 100123. doi: 10.1016/j.crmicr.2022.100123

11. Thomas A, Sachse K, Farnir F, et al. Adherence of Mycoplasma bovis to bovine bronchial epithelial cells. Microb Pathog 2003; 34(3): 141–8. doi: 10.1016/s0882-4010(03)00003-2

12. Thomas A, Dizier I, Linden A, et al. Conservation of the uvrC gene sequence in Mycoplasma bovis and its use in routine PCR diagnosis. Vet J 2004; 168(1): 100–2. doi: 10.1016/j.tvjl.2003.10.006

13. Perez-Casal J, Prysliak T. Detection of antibodies against the Mycoplasma bovis glyceraldehyde-3-phosphate dehydrogenase protein in beef cattle. Microb Pathog 2007; 43(5/6): 189–97. doi: 10.1016/j.micpath.2007.05.009

14. Thomas A, Linden A, Mainil J, et al. The p40* adhesin pseudogene of Mycoplasma bovis. Vet Microbiol 2004; 104(3/4): 213–7. doi: 10.1016/j.vetmic.2004.09.009

15. Lysnyansky, I, Ayling RD. Mycoplasma bovis: mechanisms of resistance and trends in antimicrobial susceptibility. Front Microbiol 2016; 7: 595. doi: 10.3389/fmicb.2016.00595

16. Barberio A, Flaminio B, De Vliegher S, et al. Short communication: in vitro antimicrobial susceptibility of Mycoplasma bovis isolates identified in milk from dairy cattle in Belgium, Germany, and Italy. J Dairy Sci 2016; 99(8): 6578–84. doi: 10.3168/jds.2015-10572

17. Klein U, de Jong A, Youala M, et al. New antimicrobial susceptibility data from monitoring of Mycoplasma bovis isolated in Europe. Vet Microbiol 2019; 238: 108432. doi: 10.1016/j.vetmic.2019.108432

18. Blanchard A, Bébéar CM. Mycoplasmas of humans. In: Razin S., eds. Molecular biology and pathogenicity of mycoplasmas. Berlin: Springer, 2002: 45-71.

19. Freundt E, Andrews B, Ernø H, et al. The sensitivity of Mycoplas-matales to sodium-polyanethol-sulfonate and digitonin. Zentralbl Bakteriol Parasitenkd Infektionskr Hyg 1973; 225(1): 104–12.

20. Ernø H., Stipkovits L. Bovine mycoplasmas: cultural and biochemical studies. Acta Vet Scand 1973; 14(3): 436–49.

21. Howard W, eds. Textbook of mycoplasmosis in animals: laboratory diagnosis. Ames: Iowa State Univerity Press, 1994.

22. Queipo-Ortuño MI, De Dios Colmenero J, Macias M, et al. Preparation of bacterial DNA template by boiling and effect of immunoglobulin G as an inhibitor in real-time PCR for serum samples from patients with brucellosis. Clin Vaccine Immunol 2008; 15(2): 293–6. doi:10.1128/CVI.00270-07

23. Bradbury JM, Yavari CA, Giles C. In vitro evaluation of various antimicrobials against Mycoplasma gallisepticum and Mycoplasma synoviae by the micro‐broth method, and comparison with a commercially‐prepared test system. Avian Pathol 1994; 23(1): 105–15. doi: 10.1080/03079459408418978

24. Senterfit L, Taylor-Robinson D, Niitu Y, et al. Round table II: Anti-mycoplasmal substances. Yale J Biol Med 1983; 56(5/6): 831–4.

25. CLSI. CLSI VET01S: Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals, 5th ed. Malveran: Clinical and Laboratory Standards Institute, 2018.

26. Nicholas R, Ayling R, McAuliffe L. Mycoplasma mastitis. Vet Rec 2007; 160(11): 382. doi: 10.1136/vr.160.11.382-b

27. Jasper D. The role of Mycoplasma in bovine mastitis. J Am Vet Med Assoc 1982; 181(2): 158–62.

28. Kawai K, Higuchi H, Iwano H, et al. Antimicrobial susceptibilities of Mycoplasma isolated from bovine mastitis in Japan. Anim Sci J 2014; 85(1): 96–9. doi: 10.1111/asj.12144

29. Justice-Allen A, Trujillo J, Corbett R, et al. Survival and replication of Mycoplasma species in recycled bedding sand and association with mastitis on dairy farms in Utah. J Dairy Sci 2010; 93(1): 192–202. doi: 10.3168/jds.2009-2474

30. Subramaniam S, Bergonier D, Poumarat F, et al. Species identification of Mycoplasma bovis and Mycoplasma agalactiae based on theuvrC genes by PCR. Mol Cell Probes 1998; 12(3): 161–9. doi: 10.1006/mcpr.1998.0160

31. Bokma J, Vereecke N, De Bleecker K, et al. Phylogenomic analysis of Mycoplasma bovis from Belgian veal, dairy and beef herds. Vet Res 2020; 51(1): 121. doi: 10.1186/s13567-020-00848-z

32. El-Tawab A, Awad A, Elhofy F, et al. Identification and genetic characterization of Mycoplasma species affecting respiratory system in Egyptian cattle. Benha Vet Med J 2021; 40(1): 21–6. doi: 10.21608/bvmj.2021.67213.1361

33. Mohammed Z, Saad A, Deif H. Hydrogen sulphide, an avant-garde potential virulence factor of Mycoplasma bovis isolated from the lungs of the Camelus dromedarius exhibiting silent pneumonia: virulence, antimicrobial resistance and phylogeny. Authorea Preprints, 2020. doi: 10.22541/au.159986250.04612374

34. Eissa S, Hassan A, Hashem Y, et al. Comparative molecular study of Mycoplasma bovis isolates from Egyptian buffaloes and cows suffered from mastitis. Eur J Biol Sci 2012; 4(4): 114–20. doi: 10.5829/idosi.ejbs.2012.4.4.6668

35. Cai HY, McDowall R, Parker L, et al. Changes in antimicrobial susceptibility profiles of Mycoplasma bovis over time. Can J Vet Res 2019; 83(1): 34–41.

36. Gautier-Bouchardon AV, Ferre S, Le Grand D, et al. Overall decrease in the susceptibility of Mycoplasma bovis to antimicrobials over the past 30 years in France. PLoS One 2014; 9(2): e87672. doi: 10.1371/journal.pone.0087672

37. Yleana R. In vitro amplification of the 16S rRNA genes from Mycoplasma bovis and Mycoplasma agalactiae by PCR. Vet Microbiol 1995; 47: 183–90. doi: 10.1016/0378-1135(95)00058-i

Downloads

Published

2024-12-31

How to Cite

Gioushy, M., Abdelaziz Soliman, E. E., Elkenany, R. M., El-Alfy, E.-S., Abd Elaal, A., Abd-El Razik, K. A.-E. H., & El-Khodery, S. (2024). MOLECULAR CHARACTERIZATION, VIRULENCE, AND ANTIMICROBIAL SUSCEPTIBILITY OF MYCOPLASMA BOVIS ASSOCIATED WITH CHRONIC MASTITIS IN DAIRY COWS: Mycoplasma bovis in dairy cows. Slovenian Veterinary Research, 61(4), 271–9. https://doi.org/10.26873/SVR-1882-2024

Issue

Section

Original Research Article

Most read articles by the same author(s)